These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12792668)

  • 21. Plasticity of purine release during cerebral ischemia: clinical implications?
    Pearson T; Currie AJ; Etherington LA; Gadalla AE; Damian K; Llaudet E; Dale N; Frenguelli BG
    J Cell Mol Med; 2003; 7(4):362-75. PubMed ID: 14754505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine signaling and function in glial cells.
    Boison D; Chen JF; Fredholm BB
    Cell Death Differ; 2010 Jul; 17(7):1071-82. PubMed ID: 19763139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromodulation and metamodulation by adenosine: Impact and subtleties upon synaptic plasticity regulation.
    Sebastião AM; Ribeiro JA
    Brain Res; 2015 Sep; 1621():102-13. PubMed ID: 25446444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functions of neuronal adenosine receptors.
    Haas HL; Selbach O
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):375-81. PubMed ID: 11111831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors.
    Cunha RA
    Neurochem Int; 2001 Feb; 38(2):107-25. PubMed ID: 11137880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan, adenosine, neurodegeneration and neuroprotection.
    Stone TW; Forrest CM; Mackay GM; Stoy N; Darlington LG
    Metab Brain Dis; 2007 Dec; 22(3-4):337-52. PubMed ID: 17712616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia.
    Kase H
    Biosci Biotechnol Biochem; 2001 Jul; 65(7):1447-57. PubMed ID: 11515525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET Imaging of Adenosine Receptors in Diseases.
    Li J; Hong X; Li G; Conti PS; Zhang X; Chen K
    Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.
    Chiu GS; Freund GG
    Metabolism; 2014 Dec; 63(12):1491-8. PubMed ID: 25308443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Roles of adenosine receptors in Alzheimer's disease].
    Yan R; Hu ZY; Zhou WX; Wang Q; Zhang YX
    Yao Xue Xue Bao; 2014 Jun; 49(6):751-6. PubMed ID: 25212017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of adenosine A1 receptors initiates short-term synaptic depression in rat striatum.
    Lovinger DM; Choi S
    Neurosci Lett; 1995 Oct; 199(1):9-12. PubMed ID: 8584233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of seizures and synaptic plasticity by adenosinergic receptors in an experimental model of temporal lobe epilepsy induced by pilocarpine in rats.
    Vianna EP; Ferreira AT; Doná F; Cavalheiro EA; da Silva Fernandes MJ
    Epilepsia; 2005; 46 Suppl 5():166-73. PubMed ID: 15987273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The mechanisms of depression by benzodiazepines, barbiturates and propofol of excitatory synaptic transmissions mediated by adenosine neuromodulation].
    Narimatsu E; Niiya T; Kawamata M; Namiki A
    Masui; 2006 Jun; 55(6):684-91. PubMed ID: 16780077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the neuronal network activity by P2X receptors and their involvement in neurological disorders.
    Sáez-Orellana F; Godoy PA; Silva-Grecchi T; Barra KM; Fuentealba J
    Pharmacol Res; 2015 Nov; 101():109-15. PubMed ID: 26122853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenine nucleotides as inhibitors of synaptic transmission: role of localised ectonucleotidases.
    Sebastião AM; Cunha RA; Cascalheira JF; Ribeiro JA
    Prog Brain Res; 1999; 120():183-92. PubMed ID: 10550997
    [No Abstract]   [Full Text] [Related]  

  • 36. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
    Fumagalli M; Lecca D; Abbracchio MP
    Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine A2A receptors and neuroprotection.
    Ongini E; Adami M; Ferri C; Bertorelli R
    Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.
    Franco R
    J Neural Transm (Vienna); 2009 Aug; 116(8):983-7. PubMed ID: 19002553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
    Burnstock G
    Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective role of adenosine in the CNS.
    Wardas J
    Pol J Pharmacol; 2002; 54(4):313-26. PubMed ID: 12523485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.